Elon Musk’s Neuralink has said it’s about to begin testing a technology that could enable someone with paralysis to control a ...

Neuralink has announced its entering the next phase of development of a brain-computer interface that involves the use of ...

Neuralink commenced its first human clinical trial in January 2024 by implanting a BCI device in a patient named Noland ...

Elon Musk's brain-computer interface (BCI) startup, Neuralink, announces it will test whether a person can contrrol a robotic ...

Neuralink said it has received a green light for a new clinical study to test the feasibility of connecting its ...

Elon Musk’s brain implant company is launching a new study to test whether its wireless device can control a robotic arm.

Morgan Stanley's latest report pegs the BCI market at $400 billion — signaling to investors that this revolutionary ...

Neuralink says that the study's launch is an important step towards restoring not just digital but also physical freedom.

Neuralink is trial testing a fully-implantable brain-computer interface (BCI) aims to help individuals with quadriplegia ...

Neuralink has already implanted the device in two patients. It has allowed the first patient to play video games, browse the ...

The company wants more workers in Texas and California to produce its brain implants and the surgical robot designed to ...

Neuralink, the brain-technology company co-founded by Elon Musk, has announced the launch of the PRIME Study, a clinical trial for its fully implantable, wireless brain-computer interface (BCI).